FDA Import Refusal 799-6353502-3/11/1 — Shilpa Pharma Lifesciences Limited
The FDA refused shipment 799-6353502-3/11/1 from Shilpa Pharma Lifesciences Limited (India) on November 29, 2018. The refused product falls under Drugs and Biologics — ANTI-NEOPLASTIC N.E.C.. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- November 29, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ICZ99 ANTI-NEOPLASTIC N.E.C.
- Charges
- 75